APA

Shinzawa H., Yoshida Y., Masamune O., Toyota T., Takahashi T., Kasukawa R., Sudo T., Ishikawa K., Komatsu M., Ishii M., Takagi T., Hisamichi S., Sato S. & Ichida H. (20000504). Analysis of biochemical and virological efficacy of human lymphoblastoid interferon (IFN) in patients with compensated type C liver cirrhosis: comparative study between increase in individual IFN dose and prolonging of treatment period, using a multicenter randomized controlled trial. : Digestive diseases and sciences.

Chicago

Shinzawa H, Yoshida Y, Masamune O, Toyota T, Takahashi T, Kasukawa R, Sudo T, Ishikawa K, Komatsu M, Ishii M, Takagi T, Hisamichi S, Sato S and Ichida H. 20000504. Analysis of biochemical and virological efficacy of human lymphoblastoid interferon (IFN) in patients with compensated type C liver cirrhosis: comparative study between increase in individual IFN dose and prolonging of treatment period, using a multicenter randomized controlled trial. : Digestive diseases and sciences.

Harvard

Shinzawa H., Yoshida Y., Masamune O., Toyota T., Takahashi T., Kasukawa R., Sudo T., Ishikawa K., Komatsu M., Ishii M., Takagi T., Hisamichi S., Sato S. and Ichida H. (20000504). Analysis of biochemical and virological efficacy of human lymphoblastoid interferon (IFN) in patients with compensated type C liver cirrhosis: comparative study between increase in individual IFN dose and prolonging of treatment period, using a multicenter randomized controlled trial. : Digestive diseases and sciences.

MLA

Shinzawa H, Yoshida Y, Masamune O, Toyota T, Takahashi T, Kasukawa R, Sudo T, Ishikawa K, Komatsu M, Ishii M, Takagi T, Hisamichi S, Sato S and Ichida H. Analysis of biochemical and virological efficacy of human lymphoblastoid interferon (IFN) in patients with compensated type C liver cirrhosis: comparative study between increase in individual IFN dose and prolonging of treatment period, using a multicenter randomized controlled trial. : Digestive diseases and sciences. 20000504.